Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MMP
276
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $298M | 0.07% |
6,091,071
-540,535
| -8% | -$26.2M |
|
277
T-Mobile US
TMUS
$195B
| $297M | 0.07% |
2,051,090
+404,660
| +25% | +$55.8M |
|
278
AvalonBay Communities
AVB
$27.5B
| $297M | 0.07% |
1,420,793
-106,467
| -7% | -$21.3M |
|
279
NetEase
NTES
$83B
| $296M | 0.07% |
2,564,090
-389,316
| -13% | -$42.9M |
|
280
T. Rowe Price
TROW
$25.5B
| $293M | 0.07% |
1,479,481
+365,458
| +33% | +$68.3M |
|
281
Lockheed Martin
LMT
$131B
| $292M | 0.07% |
772,518
+15,577
| +2% | +$5.99M |
|
282
West Pharmaceutical
WST
$23.7B
| $292M | 0.07% |
812,964
-324,378
| -29% | -$107M |
|
283
Vanguard Morningstar Value ETF
VTV
$188B
| $292M | 0.07% |
2,123,029
+74,883
| +4% | +$10.3M |
|
284
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $292M | 0.07% |
594,155
+47,366
| +9% | +$23.4M |
|
285
PUT
Salesforce
CRM
$154B
| $292M | 0.07% |
1,194,200
+285,500
| +31% | +$65.8M |
|
286
Biogen
BIIB
$30.9B
| $291M | 0.07% |
841,078
+3,518
| +0.4% | +$1.07M |
|
287
CME Group
CME
$95.4B
| $291M | 0.07% |
1,367,889
-89,992
| -6% | -$19M |
|
288
CALL
Meta Platforms (Facebook)
META
$1.49T
| $290M | 0.06% |
833,300
-519,800
| -38% | -$167M |
|
289
Ecolab
ECL
$79.8B
| $289M | 0.06% |
1,404,665
+137,948
| +11% | +$30M |
|
290
Northern Trust
NTRS
$21.8B
| $287M | 0.06% |
2,486,355
+70,373
| +3% | +$8.07M |
|
291
Crown Castle
CCI
$34.6B
| $287M | 0.06% |
1,472,355
-482,893
| -25% | -$90.4M |
|
292
Targa Resources
TRGP
$56.8B
| $286M | 0.06% |
6,443,083
-1,055,582
| -14% | -$40.9M |
|
293
Microchip Technology
MCHP
$38.8B
| $286M | 0.06% |
3,814,306
-458,844
| -11% | -$35M |
|
294
Post Holdings
POST
$4.42B
| $285M | 0.06% |
4,007,855
+3,585,552
| +849% | +$264M |
|
295
Veeva Systems
VEEV
$33.8B
| $284M | 0.06% |
913,019
-41,751
| -4% | -$11.6M |
|
296
Jefferies Financial Group
JEF
$12.7B
| $284M | 0.06% |
8,672,300
-568,341
| -6% | -$17.3M |
|
297
PUT
Netflix
NFLX
$307B
| $282M | 0.06% |
5,343,000
-1,142,000
| -18% | -$58.4M |
|
298
Alerian MLP ETF
AMLP
$12.9B
| $280M | 0.06% |
7,682,598
-3,487,486
| -31% | -$120M |
|
299
Align Technology
ALGN
$12.9B
| $279M | 0.06% |
457,299
+148,459
| +48% | +$87.9M |
|
300
Vertex Pharmaceuticals
VRTX
$123B
| $278M | 0.06% |
1,378,017
-284,549
| -17% | -$59.5M |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.